Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Fuchs Henry J
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   222,228    

Indirect Shares

   0      
Direct Value   $18,063,061    

Indirect Value

   $0      
Total Shares   222,228      
Total Value   $18,063,061      


Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296 Onyx Pharmaceuticals Inc $0 Biomarin Pharmaceutical Inc $17,448,765 Mirati Therapeutics, Inc. $614,296
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX EVP & Chief Medical Of... 2008-11-18 14,891 2006-05-15 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2012-06-19 0 2007-12-05 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN President, Worldwide R&D 2024-03-15 196,872 2009-03-02 0    Premium*  
            Genomic Health Inc GHDX Director 2019-11-08 0 2014-04-01 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2023-01-20 10,465 2020-01-03 0    Premium*  
* Premium Members only  

Records found :    294         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-02-24 4 A $0.00 $0 D/D 87,537 160,383 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-02-29 4 D $81.87 $4,622,708 D/D (56,464) 103,919 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-03-03 4 D $89.57 $272,562 D/D (3,043) 100,876 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-03-15 4 A $0.00 $0 D/D 19,790 120,666 0 -
GHDX Genomic Health Inc Director   –       •      –    2016-04-01 4 A $25.48 $9,988 D/D 392 3,233 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-04-29 4 A $51.26 $21,275 D/D 415 121,081 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-06 4 D $80.80 $252,985 D/D (3,131) 117,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-13 4 D $82.71 $168,398 D/D (2,036) 115,914 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-26 4 S $87.34 $1,317,100 D/D (15,000) 115,914 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-05-26 4 OE $26.49 $397,350 D/D 15,000 130,914 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-06-03 4 D $90.00 $183,240 D/D (2,036) 113,878 0 -
GHDX Genomic Health Inc Director   –       •      –    2016-07-01 4 A $26.74 $9,974 D/D 373 3,606 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-08-26 4 AS $95.06 $1,425,924 D/D (15,000) 113,878 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Medical Officer   •       –      –    2016-08-26 4 OE $26.49 $397,350 D/D 15,000 128,878 0 -
GHDX Genomic Health Inc Director   –       •      –    2016-10-01 4 A $28.92 $9,977 D/D 345 3,951 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2016-11-25 4 AS $87.40 $1,310,988 D/D (15,000) 113,878 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2016-11-25 4 OE $26.49 $397,350 D/D 15,000 128,878 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-01-01 4 A $29.39 $9,993 D/D 340 4,291 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-02-24 4 OE $26.49 $397,350 D/D 15,000 143,442 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-02-24 4 AS $87.99 $1,319,850 D/D (15,000) 128,442 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-02-24 4 A $0.00 $0 D/D 14,564 128,442 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-03-03 4 D $93.95 $274,710 D/D (2,924) 125,518 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-03-15 4 D $92.50 $473,230 D/D (5,116) 120,402 0 -
BMRN Biomarin Pharmaceutical I... President, Worldwide R&D   •       –      –    2017-03-22 4 A $0.00 $0 D/D 19,790 140,192 0 -
GHDX Genomic Health Inc Director   –       •      –    2017-04-01 4 A $31.49 $9,982 D/D 317 4,608 0 -
  294  Records found
  1   2   3   4   5   6   7   8  9   10   11   12      
  Page 8 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us